TRK INHIBITORS

Cancer is a sneaky opponent. It uses various tricks to grow and spread. One of its tools is a protein called TRK. This protein is part of a larger group of proteins that act like cell switches. When these switches are activated by specific signals, they can cause cancer cells to grow and spread. So

Scientists are exploring a drug called larotrectinib to fight tumors with a specific gene issue. This drug has shown promise against certain cancers linked to a gene called NTRK. But how well does it work against cancers where NTRK is overactive, not just fused? A new clinical trial is trying to fin